NIH-funded research NIH-funded research

Platform for Analyzing Mutations Linked to Schizophrenia (PAMS)

Official title: Platform for Analyzing the Mutations associated with Schizophrenia (PAMS)

Funded at Howard University · NIH-11392519 · Data updated 2026-11-12

A computational tool built to study rare genetic mutations in schizophrenia and predict how they affect proteins and their interactions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionHoward University
NIH-funded
Lab location1 site (Washington, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2029
Funding year2026
Award (this year)$137,060
NIH project number5R16GM159167-02
Project IDNIH-11392519 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals with schizophrenia or those who carry identified risk mutations or participate in related genomic studies.

Less likely to help

Patients without access to genomic data or those not affected by schizophrenia may not directly benefit.

What this research studies

This project will create PAMS, a user-friendly platform that combines structure-based energy calculations with gene- and sequence-based machine learning to study mutations associated with schizophrenia. Using AlphaFold structures and computational mutagenesis, it will estimate how missense mutations change protein stability and how they alter interactions with partner proteins. The tool will integrate data from a meta-analysis of 921 genes to provide a broad view of potential mutation effects. Co-immunoprecipitation experiments will help validate predicted changes in protein binding.

Why it matters

Potential benefit: If successful, patients could benefit from faster insights into how specific mutations might contribute to schizophrenia and related targets for future therapies.

How similar studies have gone: Previous work shows that structure-based and sequence-based predictions can forecast mutation impacts, suggesting potential for accurate predictions in this area.

Where this research is happening

  • Howard University
    Washington, United States
    Active

Researchers

  • Principal investigator: Teng, Shaolei — Howard University
  • Study coordinator: Teng, Shaolei

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.